A CAR-T Assessment and Treatment Mobile Optimized Website
This is a project to develop a mobile optimized website as a method of bringing urgent and lifesaving toxicity management for a group of drugs to the fingertips of bedside clinicians. In order to create an accurate and valuable experience for bedside clinicians who treat patients receiving these drugs a prototype MOW is being enhanced and polished. The hope is that nurses, pharmacists, and providers at UMMC and other cancer centers will use this MOW regularly to help treat patients.
- Tracy T Douglas, DNP, RN Greenebaum Comprehensive Cancer Center
- Saurabh Dahiya, MD, MBS, Greenebaum Comprehensive Cancer Center
- Kathleen Ruehle, RN, Greenebaum Comprehensive Cancer Center
- Jennifer Nishioka PharmD, BCOP, Pharmacy
- Cathy Karska, BSN, RN, Greenebaum Comprehensive Cancer Center
- Eun-Shim Nahm, PhD, RN, FAAN, UMB SON
- Noah Max Rapoport, Columbia University
- Matthew J. Rosenberg, Columbia University
June 2022 Updates
Through the support of the innovation grant we have been able to create a mobile optimized website (MOW) to help providers care for cancer patients who receive CAR T drugs. Clinicians who are experienced and knowledgeable about CAR T have had the opportunity to work with programmers, marketing, and others to bring our request to life.
At this point we are finalizing the MOW and preparing it for testing prior to launching it to UMMC.
The team has successfully developed a mobile optimized website that helps health care teams with quick decision-making support to standardize assessment and emergency treatments for patients receiving highly regulated and toxic CAR-T drugs.
The mobile optimized app includes FDA inserts of six CAR-T drugs. Pre and post tests have shown an uptake in usage by providers. The team has received positive feedback on the usability of the app.
The app has implications for IP rights, and the team will continue to investigate possibilities for expanding usage.